Edition:
India

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

1.45USD
16 Feb 2018
Change (% chg)

$0.01 (+0.69%)
Prev Close
$1.44
Open
$1.45
Day's High
$1.49
Day's Low
$1.41
Volume
34,895
Avg. Vol
101,710
52-wk High
$98.00
52-wk Low
$1.39

Select another date:

Tue, Feb 6 2018

BRIEF-Argos Obtains Option To License PD1 Checkpoint Inhibitors

* ARGOS THERAPEUTICS INC - ENTERED INTO AN OPTION AGREEMENT WITH PHARMSTANDARD INTERNATIONAL, S.A. AND ACTIGEN LIMITED

BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close

* ARGOS THERAPEUTICS - BOARD APPROVED ONE-FOR-TWENTY REVERSE SPLIT OF CO'S COMMON STOCK THAT WILL TAKE EFFECT JANUARY 18, AFTER CLOSE OF TRADING Source text for Eikon: Further company coverage:

BRIEF-Argos Announces $1.5 Million Equity Investment By Lummy (Hong Kong) Ltd

* ARGOS ANNOUNCES $1.5 MILLION EQUITY INVESTMENT BY LUMMY (HONG KONG), LTD. Source text for Eikon: Further company coverage:

BRIEF-Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp

* ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING

BRIEF-Argos Provides Financial Update

* ARGOS THERAPEUTICS - ‍TKC PROPERTIES HAS, WITH ARGOS' FULL CONSENT, SUCCESSFULLY COMPLETED SALE OF FACILITY IN DURHAM COUNTY, NC TO A THIRD PARTY​

BRIEF-Argos reports third quarter financial results

* Argos reports third quarter 2017 financial results and operational highlights

BRIEF-Argos Therapeutics files for offering of 13.5 mln shares of common stock by Invetech

* Argos Therapeutics files for offering of 13.5 million shares of common stock by Invetech Pty Ltd - SEC filing Source text: (http://bit.ly/2zcHDkV) Further company coverage:

BRIEF-Argos Therapeutics enters into agreement with Invetech

* Argos Therapeutics - On September 22, 2017 co entered into a satisfaction and release agreement with Invetech PTY Ltd ‍​ - SEC filing

BRIEF-‍Argos doses first HIV patient with AGS-004

* ‍Argos announces first dosing of HIV patient with AGS-004 derived from latent viral reservoir​

Select another date: